日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial

激光间质热疗联合帕博利珠单抗辅助治疗复发性高级别星形细胞瘤:一项 I 期/随机 IIb 期试验

Campian, Jian L; Le, Son B; Ghiaseddin, Ashley; Butt, Omar H; Manektalia, Harshit; Chen, Dongjiang; Xu, Yifei; Liu, Jingxia; Rahman, Maryam; Thai, Nathan; Leidig, William A; Johanns, Tanner; Ansstas, George; Zhou, Alice Y; Pugazenthi, Sangami; Dunn, Gavin P; Huang, Jiayi; Chheda, Milan G; Kim, Albert H; Leuthardt, Eric C; Tran, David D

Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma

对I期至IIIB期黑色素瘤患者进行术后疾病监测的纵向ctDNA监测

Ansstas, George; Khaddour, Karam; Sudhaman, Sumedha; Lin, Karen; Budde, Griffin L; Poklepovic, Andrew; Doonan, Bently P; Mooradian, Meghan J; Sullivan, Ryan J; Ma, Vincent T; Rosiecki, Jeremy; Liu, Steven; Drengler, Ronald; Flora, Daniel B; Beasley, Georgia M; Rhodin, Kristen E; Hyngstrom, John R; Brunsgaard, Elise K; Ortiz, J Bryce; George, Giby V; Krainock, Michael; Liu, Minetta C; Tan, Alan

Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient Cohort

皮肤癌中的同源重组缺陷:这一特殊患者群体的患病率和临床意义

Nassief, George; Adeyelu, Tolulope; Elliott, Andrew; Phillipps, Jordan; Morecroft, Renee; Zhou, Alice Y; Szlosarek, Peter W; Robert, Caroline; Abdulla, Farah; Vanderwalde, Ari; Park, Soo J; Chen, David; Ansstas, George

Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors

一项评估 TLR9 激动剂 cavrotolimod 与抗 PD-1 抗体联合治疗晚期实体瘤患者的安全性、有效性和免疫效应的 1b/2 期研究

Milhem, Mohammed M; Wise-Draper, Trisha M; Chandra, Sunandana; Hanna, Glenn J; Laux, Douglas E; Medina, Theresa M; Ansstas, George; Daud, Adil; Kelly, Ciara M; O'Day, Steven J; Perez, Cesar A; Wong, Michael K; Friedlander, Philip A; Kristedja, Timothy S; Burgess, Melissa A; Cowey, C Lance; Hanks, Brent A; Weight, Ryan M; Daniel, Weston L; Feltner, Douglas E; Mix, Scott; Sindelar, Laurel; Bexon, Alice S; Bexon, Martin F; Michel, Robert E; Bhatia, Shailender

Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanoma

talimogene laherparepvec 作为晚期黑色素瘤挽救疗法的真实世界疗效

Yamada, Melissa M; Chandrasekhar, Smitha; Gooley, Ted A; Chen, Rita E; Doolittle-Amieva, Coley; Ansstas, George; Bhatia, Shailender; Hall, Evan T; Nghiem, Paul T; Park, Song Y; Chen, David Y

PARP inhibitors in melanoma treatment: potential, challenges, and future directions

PARP抑制剂在黑色素瘤治疗中的应用:潜力、挑战和未来方向

Anaeme, Angela; Moussa, Karen; Mansour, Abdallah N; Nassief, George; Ansstas, George

Eccrine carcinomas and homologous recombination repair cancer predisposition genes: A case series

汗腺癌与同源重组修复癌症易感基因:病例系列研究

Morecroft, Renée; Phillipps, Jordan; Barozinsky, Kaiden; Jones, Susan; Sun, Lulu; Crites, Danielle; Butt, Omar; Ansstas, George; Grierson, Patrick; Johanns, Tanner M; Zhou, Alice

Targeted therapies and PARPi therapy response following ICI therapy failure in advanced melanoma: a case series

晚期黑色素瘤免疫检查点抑制剂治疗失败后靶向治疗和PARP抑制剂治疗的反应:病例系列研究

Nassief, George; Morecroft, Renee; Phillipps, Jordan; Chen, David; Ansstas, George

Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma

晚期黑色素瘤中BRAF/MEK靶向治疗失败后PARP抑制剂治疗的疗效

Phillipps, Jordan; Nassief, George; Morecroft, Renee; Adeyelu, Tolulope; Elliott, Andrew; Abdulla, Farah; Vanderwalde, Ari; Park, Soo; Butt, Omar; Zhou, Alice; Ansstas, George

Recent Advancements in Cell-Based Therapies in Melanoma

黑色素瘤细胞疗法的最新进展

Nassief, George; Anaeme, Angela; Moussa, Karen; Mansour, Abdallah N; Ansstas, George